COVID19 Road to a vaccine episode 9: Professor Robert Booy

In episode 9 of our COVID19 Road to a vaccine series, our host, Associate Professor Nigel Crawford, speaks with Professor Robert Booy. Robert is a Professor of Paediatrics and Child Health at the University of Sydney and is a Senior Professorial Fellow at NCIRS, the National Centre for Immunisation Research and Surveillance at Westmead Children’s Hospital. He has special research interests in serious infections and their prevention, particularly in the setting of aged care facilities. In this episode they discuss:

  • Special risk groups when it comes to SARS-CoV-2, in particular, those living and working in aged care facilities
  • How the ageing process leads to immunosenescence and the impact of this on vaccine efficacy in the elderly population
  • The use of adjuvants in vaccines for the elderly population
  • How to improve public health messaging and the management of respiratory illnesses in aged care facilities
  • Lessons learnt from around the world with high mortality rates in aged care residents and workers and how that can inform the response to outbreaks in aged care facilities in Australia

लिंक:

Listen to the episode here:

स्प्रेकर - सेब - Spotify 

 

 

द्वारा ऐलिस ब्लैक

The virus and the clock, with Moderna's Tal Zaks- A podcast with the Milken Institute

In this podcast, the Milken Institute interviews Tal Zaks, the Chief Medical Officer of Moderna Therapeutics to discuss the development of their COVID-19 vaccine candidate using messenger RNA (mRNA) technology. It took them only 63 days from the time the virus was sequenced until the vaccine candidate began human clinical trials. It is hoped that this new technology may also be adapted as possible treatments for other genetic diseases. 

Listen to the podcast यहाँ

 

द्वारा ऐलिस ब्लैक

NDTV speak to Professor Kanta Subbarao, Director of WHO Collaborating Centre for Reference and Research on Influenza

NDTV have spoken to Professor Kanta Subbarao, Director of the WHO Collaborating Centre For Reference And Research On Influenza in Melbourne, Australia about the race for a SARS-CoV-2 vaccine and the possibility of developing herd immunity.
Watch the video interview here:
In June, we spoke to Professor Subbarao in our एक वैक्सीन के लिए COVID19 रोड podcast series, access the episode here:

द्वारा ऐलिस ब्लैक

COVID19 Road to a vaccine episode 8: Professor Katie Flanagan

In episode 8 of our COVID19 Road to a vaccine series, our host, Associate Professor Nigel Crawford, speaks with Professor Katie Flanagan. Katie is Head of Infectious Diseases at Launceston General Hospital and is affiliated with the University of Tasmania, Monash University and RMIT where she is involved in a broad range of research projects, with her main interests being in vaccinology and infectious diseases immunology. She has led a number of vaccine immunology trials. In this episode they discuss:

  • Immunological aspects of SARS-CoV-2
  • Vaccine responses in adults versus children and the difference in adult immune systems
  • Vaccinology strategies being used in the development of a SARS-CoV-2 vaccine
  • Antibody response variation by age
  • Viral vector vaccines and how they work
  • Novel vaccine approaches and the implications of these on vaccine safety including: mRNA and DNA SARS-CoV-2 vaccines 

लिंक:

Download the episode:

स्प्रेकर - सेब - Spotify 

 

द्वारा ऐलिस ब्लैक

Questions and answers about COVID-19 vaccines

The Vaccine Education Center (VEC) at the Children's Hospital of Philadelphia (CHoP) has recently launched a new resource page answering common questions related to the development and safety of COVID-19 vaccines. Readers are also encouraged to submit their own questions directly to the VEC team for response.

To access this initiative please follow the link यहाँ

द्वारा ऐलिस ब्लैक

Coronavirus vaccine progress report: the projects bidding to win the race for a COVID-19 vaccine

With over 140 vaccine candidates in various stages of development globally, the ABC has taken a look at the role that Australian researchers are playing in the effort to produce a safe and effective vaccine for COVID-19. 

ABC: Coronavirus vaccine progress:the projects bidding to win the race for a COVID-19 vaccine 

To further explore the COVID-19 vaccine development process and hear from a variety of national and international experts, please subscribe to our podcast series:
COVID-19 Road to a vaccine 

द्वारा ऐलिस ब्लैक

New immunisation reference page: Vaccine development and safety

In an effort to promote confidence in the safety and efficacy of immunisation, MVEC has looked at the steps undertaken by vaccine candidates prior to being registered for use in vaccination programs. Post-licensure surveillance programs are also important for the early detection of any unexpected safety signals that may arise.

To learn more please visit our MVEC page Vaccine development and safety

द्वारा ऐलिस ब्लैक

COVID19 Road to a vaccine episode 7: Professor Norman Baylor

In episode 7 of our COVID19 Road to a vaccine series, our host, Associate Professor Nigel Crawford speaks with Professor Norman Baylor. Professor Baylor is the former Director of the Office of Vaccines Research and Review Center at the U.S. Food and Drug Administration (FDA) and is the President and CEO of Biologics Consulting and current advisor to the WHO.

In this episode they discuss:

  • The important role of regulatory authorities in the development and release of new vaccines
  • Emergency Use Authorisations (EUA) and their use
  • Compressed timelines in the development of SARS-CoV-2 vaccines
  • Requirements of regulatory bodies in the development of vaccines
  • Opportunities for collaboration/”work-sharing” between the national regulatory bodies (FDA, EMA and TGA)
  • The role of regulatory bodies in vaccine safety

लिंक:

Download the episode at:

स्प्रेकर - सेब - Spotify 

द्वारा ऐलिस ब्लैक

COVID19 Road to a vaccine episode 6: Professor Paul Offit

In episode 6 of our COVID19 Road to a vaccine series, our host, Associate Professor Nigel Crawford, speaks to Professor Paul Offit. Professor Offit is an infectious diseases physician and Director of the Children's Hospital of Philadelphia (CHoP) Vaccine Education Center (VEC). The VEC website inspired the creation of the Melbourne Vaccine Education Centre, the host of this podcast series. 

In this episode they discuss:

  • The impact of SARS-CoV-2 on health care workers and the importance of a vaccine
  • Preventative therapies and randomised controlled trials in a pandemic, specifically the use of hydroxychloroquine for COVID-19 and the other trials involving health care workers
  • COVID-19 in children - do they play a role in transmission? Will they be a target for vaccine studies?
  • Paediatric Inflammatory Multisystem Syndrome (PIMS) - how can we factor this emerging condition into safety planning?

लिंक:

You can listen to this episode here:

स्प्रेकर - सेब - Spotify 

द्वारा ऐलिस ब्लैक

COVID19 Road to a vaccine episode 5: Professor Terry Nolan

In episode 5 of our COVID19 Road to a vaccine series, our host, Associate Professor Nigel Crawford speaks to Professor Terry Nolan. Professor Nolan is a Redmond Barry Distinguished Professor at the Doherty Institute for Infection and Immunity. He heads up VIRGO, the vaccine and immunisation research group, a collaboration between Murdoch Children's Research Institute and the University of Melbourne. VIRGO has the largest and longest standing child and adolescent vaccine population research and clinical trials program in Australia. He previously chaired ATAGI, the Australian Technical Advisory Group on Immunisation and was a member of SAGE, the World Health Organisation's main advisory group on vaccines and immunisation. They discuss the COVID-19 candidate vaccines from an Australian perspective and Australia's role in global clinical trials.  

लिंक:

Listen on:

स्प्रेकर - सेब - Spotify

द्वारा ऐलिस ब्लैक